Sanjeev Shukla

Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice

Anil Mishra, Pingfu Fu, M. Resnick, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft

S. Shukla, Sanjay Gupta, Sanjeev Shukla, 2006, Molecular Cancer Therapeutics.

Apigenin and cancer chemoprevention: progress, potential and promise (review).

S. Shukla, Sanjay Gupta, Sanjeev Shukla, 2007, International journal of oncology.

Apigenin: A Promising Molecule for Cancer Prevention

S. Shukla, Sanjay Gupta, Sanjeev Shukla, 2010, Pharmaceutical Research.

Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study.

S. Shukla, Sanjay Gupta, Sanjeev Shukla, 2008, Carcinogenesis.

Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion

Pingfu Fu, M. Resnick, G. MacLennan, 2007, International journal of cancer.

Apigenin-mediated modulations of PI3K-Akt and MAPK signaling pathways causes growth Inhibition and cell cycle arrest in human prostate cancer cells

S. Shukla, Sanjay Gupta, Sanjeev Shukla, 2007 .

TET‐catalyzed oxidation of intragenic 5‐methylcytosine regulates CTCF‐dependent alternative splicing

David Sturgill, Kyster K. Nanan, Nazmul Haque, 2016, The EMBO journal.

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

Pingfu Fu, M. Resnick, G. MacLennan, 2004, Neoplasia.

Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice

G. MacLennan, S. Shukla, N. Bhaskaran, 2013, The Prostate.

FOXO3a: A Potential Target in Prostate Cancer.

S. Shukla, Sanjeev Shukla, 2014, Austin journal of urology.